R. Guerrini, Epilepsy in children, The Lancet, vol.367, issue.9509, pp.499-524, 2006.
DOI : 10.1016/S0140-6736(06)68182-8

E. Garofalo, Obtaining pediatric indications for new anti-epileptic drugs: How and when, Epilepsy Research, vol.68, issue.1, pp.38-42, 2006.
DOI : 10.1016/j.eplepsyres.2005.09.016

B. Schmidt, Clinical development of antiepileptic drugs in adults, Neurotherapeutics, vol.112, issue.suppl 10, pp.62-69, 2007.
DOI : 10.1016/j.nurt.2006.11.013

P. Caldwell, S. Murphy, P. Butow, and J. Craig, Clinical trials in children, The Lancet, vol.364, issue.9436, pp.803-811, 2004.
DOI : 10.1016/S0140-6736(04)16942-0

J. Pellock, Pediatric trials: practical issues. Special populations and trial design, Adv Neurol, vol.76, pp.167-171, 1998.

R. Steinbrook, Testing Medications in Children, New England Journal of Medicine, vol.347, issue.18, pp.1462-1470, 2002.
DOI : 10.1056/NEJMhpr021646

E. Perucca, Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age, Clinical Pharmacokinetics, vol.5, issue.10, pp.351-363, 2006.
DOI : 10.2165/00003088-200645040-00002

S. Shinnar and J. Pellock, The trials and tribulations of pediatric drug trials, Neurology, vol.65, issue.9, pp.1348-1349, 2005.
DOI : 10.1212/01.wnl.0000183475.81594.29

A. Sandler, Placebo effects in developmental disabilities: Implications for research and practice, Mental Retardation and Developmental Disabilities Research Reviews, vol.5, issue.2, pp.164-170, 2005.
DOI : 10.1002/mrdd.20065

R. Fernandes, J. Ferreira, and C. Sampaio, The Placebo Response in Studies of Acute Migraine, The Journal of Pediatrics, vol.152, issue.4, pp.527-560, 2008.
DOI : 10.1016/j.jpeds.2007.09.024

D. Lewis, P. Winner, and W. Wasiewski, The Placebo Responder Rate in Children and Adolescents, Headache: The Journal of Head and Face Pain, vol.34, issue.3, pp.232-239, 2005.
DOI : 10.1046/j.1526-4610.1996.3607419.x

A. Rothner, W. Wasiewski, P. Winner, D. Lewis, and J. Stankowski, Zolmitriptan Oral Tablet in Migraine Treatment: High Placebo Responses in Adolescents, Headache: The Journal of Head and Face Pain, vol.17, issue.7, pp.101-109, 2006.
DOI : 10.1111/j.1526-4610.2005.05050.x

R. Beran, S. Berkovic, F. Dunagan, F. Vajda, and G. Danta, Double-Blind, Placebo-Controlled, Lamotrigine in Treatment-Resistant Generalised Epilepsy, Epilepsia, vol.35, issue.12, pp.1329-1333, 1998.
DOI : 10.1016/S0967-5868(96)90057-0

S. Berkovic, R. Knowlton, R. Leroy, J. Schiemann, and U. Falter, Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy, Neurology, vol.69, issue.18, pp.1751-1760, 2007.
DOI : 10.1212/01.wnl.0000268699.34614.d3

V. Biton, G. Montouris, F. Ritter, J. Riviello, and R. Reife, A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures, Neurology, vol.52, issue.7, pp.1330-1337, 1999.
DOI : 10.1212/WNL.52.7.1330

V. Biton, J. Sackellares, A. Vuong, A. Hammer, and P. Barrett, Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures, Neurology, vol.65, issue.11, pp.1737-1743, 2005.
DOI : 10.1212/01.wnl.0000187118.19221.e4

D. Chadwick, D. Leiderman, W. Sauermann, A. J. Garofalo, and E. , Gabapentin in generalized seizures, Epilepsy Research, vol.25, issue.3, pp.191-197, 1996.
DOI : 10.1016/S0920-1211(96)00020-4

T. Glauser, G. Kluger, R. Sachdeo, G. Krauss, and C. Perdomo, Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome, Neurology, vol.70, issue.21, pp.1950-1958, 2008.
DOI : 10.1212/01.wnl.0000303813.95800.0d

J. Motte, E. Trevathan, J. Arvidsson, M. Barrera, and E. Mullens, Lamotrigine for Generalized Seizures Associated with the Lennox???Gastaut Syndrome, New England Journal of Medicine, vol.337, issue.25, pp.1807-1812, 1997.
DOI : 10.1056/NEJM199712183372504

J. French, A. Kanner, J. Bautista, B. Abou-khalil, and T. Browne, Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society, Neurology, vol.62, issue.8, pp.1261-1273, 2004.
DOI : 10.1212/01.WNL.0000123695.22623.32

R. Gumnit and T. Walczak, Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States, Epilepsia, vol.42, pp.804-814, 2001.

E. Perruca, Pharmacoresistance in Epilepsy, CNS Drugs, vol.10, issue.3, pp.171-179, 1998.
DOI : 10.2165/00023210-199810030-00002

G. Regesta and P. Tanganelli, Clinical aspects and biological bases of drug-resistant epilepsies, Epilepsy Research, vol.34, issue.2-3, pp.109-122, 1999.
DOI : 10.1016/S0920-1211(98)00106-5

A. European-medicines, International Conference on Harmonisation . ICH topic E11 clinical investigation of medicinal products in the paediatric population Available, 2001.

A. Jadad, R. Moore, D. Carroll, C. Jenkinson, and D. Reynolds, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

D. Gazzola, L. Balcer, and J. French, Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs, Epilepsia, vol.32, issue.7, pp.1303-1307, 2007.
DOI : 10.1016/0920-1211(93)90011-U

J. Higgins and S. Thompson, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, vol.14, issue.11, pp.1539-1558, 2002.
DOI : 10.1002/sim.1186

M. Cucherat, EasyMA Sofware Version Available: http://www. spc.univ-lyon1.fr/easyma, 2000.

M. Cucherat, J. Boissel, A. Leizorovicz, and M. Haugh, EasyMA: a program for the meta-analysis of clinical trials, Computer Methods and Programs in Biomedicine, vol.53, issue.3, pp.187-190, 1997.
DOI : 10.1016/S0169-2607(97)00016-3

W. Rosenfeld, B. Abou-khalil, R. Reife, R. Hegadus, and G. Pledger, Placebo-controlled trial of topiramate as adjunctive therapy to carbamazepine or phenitoine for partial onset seizures, Epilepsia, vol.37, p.153, 1996.

D. Schmidt, R. Ried, and P. Rapp, Add-on treatment with Lamotrigine for intractable partial epilepsy: a placebo-controlled, cross-over trial, Epilepsia, vol.34, p.66, 1993.

N. Jette, A. Marson, and J. Hutton, Topiramate add-on for drugresistant partial epilepsy. Cochrane Database Syst Rev CD001417, 2002.

S. Ramaratnam, A. Marson, and G. Baker, Lamotrigine add-on for drugresistant partial epilepsy, 2001.

M. Duchowny, J. Pellock, W. Graf, C. Billard, and J. Gilman, A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children, Neurology, vol.53, issue.8, pp.1724-1731, 1999.
DOI : 10.1212/WNL.53.8.1724

T. Huedo-medina, F. Sanchez-meca, F. Marin-martinez, and J. Botella, Assessing heterogeneity in meta-analysis: Q statistic or I?? index?, Psychological Methods, vol.11, issue.2, pp.193-206, 2006.
DOI : 10.1037/1082-989X.11.2.193

J. Ioannidis, N. Patsopoulos, and E. Evangelou, Uncertainty in heterogeneity estimates in meta-analyses, BMJ, vol.335, issue.7626, pp.914-916, 2007.
DOI : 10.1136/bmj.39343.408449.80

C. Hoppe, A. Poepel, and C. Elger, Epilepsy, Archives of Neurology, vol.64, issue.11, pp.1595-1599, 2007.
DOI : 10.1001/archneur.64.11.1595

URL : https://hal.archives-ouvertes.fr/hal-00552732

F. Kerling, S. Mueller, E. Pauli, and H. Stefan, When do patients forget their seizures? An electroclinical study, Epilepsy & Behavior, vol.9, issue.2, pp.281-285, 2006.
DOI : 10.1016/j.yebeh.2006.05.010

S. Castillo, D. Schmidt, and S. White, Oxcarbazepine add-on for drugresistant partial epilepsy. Cochrane Database Syst Rev CD002028, 2000.

D. Chadwick and A. Marson, Zonisamide add-on for drug-resistant partial epilepsy Available, Cochrane Database Syst Rev CD001416, 2005.

R. Chaisewikul, M. Privitera, J. Hutton, and A. Marson, Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database Syst Rev CD001901, 2001.

J. Leach, A. Marson, and J. Hutton, Remacemide for drug-resistant localization related epilepsy. Cochrane Database Syst Rev CD001900, 2002.

D. Lozsadi, K. Hemming, and A. Marson, Pregabalin add-on for drugresistant partial epilepsy. Cochrane Database Syst Rev CD005612, 2008.

A. Marson, Z. Kadir, J. Hutton, and D. Chadwick, Gabapentin add-on for drug-resistant partial epilepsy, 2000.
DOI : 10.1002/14651858.CD001415

J. Pereira, A. Marson, and J. Hutton, Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev CD001908, Available, 2002.

A. Marson, J. Hutton, J. Leach, S. Castillo, and D. Schmidt, Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review, Epilepsy Research, vol.46, issue.3, pp.259-270, 2001.
DOI : 10.1016/S0920-1211(01)00287-X

A. Marson, Z. Kadir, J. Hutton, and D. Chadwick, The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability, Epilepsia, vol.35, issue.1, pp.859-880, 1997.
DOI : 10.1016/S0140-6736(95)90581-2

C. Otoul, C. Arrigo, K. Van-rijckevorsel, and J. French, Meta-Analysis and Indirect Comparisons of Levetiracetam With Other Second-Generation Antiepileptic Drugs in Partial Epilepsy, Clinical Neuropharmacology, vol.28, issue.2, pp.72-78, 2005.
DOI : 10.1097/01.wnf.0000159956.87511.67

R. Appleton, K. Fichtner, L. Lamoreaux, A. J. Halsall, and G. , Gabapentin as Add-On Therapy in Children with Refractory Partial Seizures: A 12-Week, Multicentre, Double-Blind, Placebo-Controlled Study, Epilepsia, vol.4, issue.8, pp.1147-1154, 1999.
DOI : 10.1016/0140-6736(90)91123-R

R. Elterman, T. Glauser, E. Wyllie, R. Reife, and S. Wu, A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children, Neurology, vol.52, issue.7, pp.1338-1344, 1999.
DOI : 10.1212/WNL.52.7.1338

H. Anhut, P. Ashman, T. Feuerstein, W. Sauermann, and M. Saunders, Gabapentin (Neurontin) as Add-on Therapy in Patients with Partial Seizures: A Double-Blind, Placebo-Controlled Study, Epilepsia, vol.36, issue.4, pp.795-801, 1994.
DOI : 10.1016/0922-4106(93)90155-3

C. Tassinari, R. Michelucci, P. Chauvel, J. Chodkiewicz, and S. Shorvon, Double-Blind, Placebo-Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy, Epilepsia, vol.36, issue.8, pp.763-768, 1996.
DOI : 10.1111/j.1528-1157.1996.tb00649.x

T. Yamauchi, S. Kaneko, K. Yagi, and S. Sase, Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study*, Psychiatry and Clinical Neurosciences, vol.62, issue.4, pp.507-515, 2006.
DOI : 10.1006/ebeh.2001.0283

J. Pina-garza, R. Espinoza, D. Nordli, D. Bennett, and S. Spirito, Oxcarbazepine adjunctive therapy in infants and young children with partial seizures, Neurology, vol.65, issue.9, pp.1370-1375, 2005.
DOI : 10.1212/01.wnl.0000186800.18456.72

C. Chiron, S. Tonnelier, E. Rey, M. Brunet, and A. Tran, Stiripentol in Childhood Partial Epilepsy: Randomized Placebo-Controlled Trial with Enrichment and Withdrawal Design, Journal of Child Neurology, vol.49, issue.6, pp.496-502, 2006.
DOI : 10.1177/08830738060210062101

C. Chiron, O. Dulac, and L. Gram, Vigabatrin withdrawal randomized study in children, Epilepsy Research, vol.25, issue.3, pp.209-215, 1996.
DOI : 10.1016/S0920-1211(96)00028-9

C. Chiron, O. Dulac, and G. Pons, Antiepileptic Drug Development in Children, Drugs, vol.21, issue.6, pp.17-25, 2008.
DOI : 10.2165/00003495-200868010-00002

J. Pina-garza, P. Levisohn, K. Gucuyener, M. Mikati, and C. Warnock, Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months Gabapentin in partial epilepsy. UK Gabapentin Study Group, Neurology Lancet, vol.64, issue.335, pp.1114-1117, 1990.

J. Sivenius, R. Kalviainen, A. Ylinen, and P. Riekkinen, Double-Blind Study of Gabapentin in the Treatment of Partial Seizures, Epilepsia, vol.39, issue.4, pp.539-542, 1991.
DOI : 10.1111/j.1528-1157.1991.tb04689.x

C. Binnie, R. Debets, M. Engelsman, J. Meijer, and H. Meinardi, Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy, Epilepsy Research, vol.4, issue.3, pp.222-229, 1989.
DOI : 10.1016/0920-1211(89)90007-7

S. Jawad, A. Richens, G. Goodwin, and W. Yuen, Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial Seizures, Epilepsia, vol.27, issue.3, pp.356-363, 1989.
DOI : 10.2307/2556170

P. Loiseau, A. Yuen, B. Duche, T. Menager, and A. Mc, A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures, Epilepsy Research, vol.7, issue.2, pp.136-145, 1990.
DOI : 10.1016/0920-1211(90)90099-H

F. Matsuo, D. Bergen, E. Faught, J. Messenheimer, and A. Dren, Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures, Neurology, vol.43, issue.11, pp.2284-2291, 1993.
DOI : 10.1212/WNL.43.11.2284

G. Schapel, R. Beran, F. Vajda, S. Berkovic, and M. Mashford, Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures., Journal of Neurology, Neurosurgery & Psychiatry, vol.56, issue.5, pp.448-453, 1993.
DOI : 10.1136/jnnp.56.5.448

D. Smith, G. Baker, G. Davies, M. Dewey, and D. Chadwick, Outcomes of Add-on Treatment with Lamotrigine in Partial Epilepsy, Epilepsia, vol.67, issue.2, pp.312-322, 1993.
DOI : 10.1016/0920-1211(92)90049-Y

J. Messenheimer, R. Ramsay, L. Willmore, R. Leroy, and J. Zielinski, Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo-Controlled, Double-Blind, Cross-Over Trial, Epilepsia, vol.33, issue.1, pp.113-121, 1994.
DOI : 10.1016/0920-1211(90)90077-9

J. Boas, M. Dam, M. Friis, O. Kristensen, and B. Pedersen, Controlled trial of lamotrigine (Lamictal??) for treatment-resistant partial seizures, Acta Neurologica Scandinavica, vol.35, issue.Suppl 8, pp.247-252, 1996.
DOI : 10.1111/j.1600-0404.1996.tb07060.x

E. Ben-menachem and U. Falter, Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double-Blind, Responder-Selected Study Evaluating Monotherapy, Epilepsia, vol.30, issue.10, pp.1276-1283, 2000.
DOI : 10.1002/ana.410320313

J. Cereghino, V. Biton, B. Abou-khalil, F. Dreifuss, and L. Gauer, Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial, Neurology, vol.55, issue.2, pp.236-242, 2000.
DOI : 10.1212/WNL.55.2.236

S. Shorvon, A. Lowenthal, D. Janz, E. Bielen, and P. Loiseau, Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures, Epilepsia, vol.310, issue.2, pp.1179-1186, 2000.
DOI : 10.1177/00912700022009369

J. Tsai, D. Yen, M. Hsih, S. Chen, and R. Hiersemenzel, Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Epilepsia, vol.27, issue.1, pp.72-81, 2006.
DOI : 10.1097/01.wnf.0000159956.87511.67

T. Glauser, R. Ayala, R. Elterman, W. Mitchell, and C. Van-orman, Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures, Neurology, vol.66, issue.11, pp.1654-1660, 2006.
DOI : 10.1212/01.wnl.0000217916.00225.3a

G. Barcs, E. Walker, C. Elger, A. Scaramelli, and H. Stefan, Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy, Epilepsia, vol.41, pp.1597-1607, 2000.

T. Glauser, M. Nigro, R. Sachdeo, L. Pasteris, and S. Weinstein, Adjunctive therapy with oxcarbazepine in children with partial seizures, Neurology, vol.54, issue.12, pp.2237-2244, 2000.
DOI : 10.1212/WNL.54.12.2237

E. Ben-menachem, O. Henriksen, M. Dam, M. Mikkelsen, and D. Schmidt, Double-Blind, Placebo-Controlled Trial of Topiramate as Add-on Therapy in Patients with Refractory Partial Seizures, Epilepsia, vol.43, issue.6, pp.539-543, 1996.
DOI : 10.1016/S0140-6736(83)90462-2

E. Faught, B. Wilder, R. Ramsay, R. Reife, and L. Kramer, Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages, Neurology, vol.46, issue.6, pp.1684-1690, 1996.
DOI : 10.1212/WNL.46.6.1684

M. Privitera, R. Fincham, J. Penry, R. Reife, and L. Kramer, Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages, Neurology, vol.46, issue.6, pp.1678-1683, 1996.
DOI : 10.1212/WNL.46.6.1678

M. Sharief, C. Viteri, E. Ben-menachem, M. Weber, and R. Reife, Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy, Epilepsy Research, vol.25, issue.3, pp.217-224, 1996.
DOI : 10.1016/S0920-1211(96)00029-0

D. Yen, H. Yu, Y. Guo, C. Chen, and C. Yiu, A Double-Blind, Placebo-Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy, Epilepsia, vol.37, issue.9, pp.1162-1166, 2000.
DOI : 10.1016/S0920-1211(96)00029-0